45.83 USD
▲-1.28+1.53%
盘后 45.03 -0.24%
2026-08-03
市值
$1.26B
市盈率
—
EPS
-0.06
股息率
—
52 周区间
13.99 – 50.18
成交量
341.77K
Beta
0.87
目标价
54.75
52W 低 13.9952W 高 50.18
价格走势
公司简介
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing vari...